首页> 美国卫生研究院文献>other >Ultra Performance Liquid Chromatography-Based Metabonomic Study of Therapeutic Effect of the Surface Layer of Poria cocos on Adenine-Induced Chronic Kidney Disease Provides New Insight into Anti-Fibrosis Mechanism
【2h】

Ultra Performance Liquid Chromatography-Based Metabonomic Study of Therapeutic Effect of the Surface Layer of Poria cocos on Adenine-Induced Chronic Kidney Disease Provides New Insight into Anti-Fibrosis Mechanism

机译:基于超高效液相色谱的Meta基因表面层对腺嘌呤诱发的慢性肾脏病治疗作用的代谢组学研究为抗纤维化机制提供了新见解

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The surface layer of Poria cocos (Fu-Ling-Pi, FLP) is commonly used in traditional Chinese medicine and its diuretic effect was confirmed in rat. Ultra performance liquid chromatography/quadrupole time-of-flight high-sensitivity mass spectrometry and a novel mass spectrometryElevated Energy data collection technique was employed to investigate metabonomic characteristics of chronic kidney disease (CKD) induced from adenine excess and the protective effects of FLP. Multiple metabolites are detected in the CKD and are correlated with progressive renal injury. Among these biomarkers, lysoPC(18∶0), tetracosahexaenoic acid, lysoPC(18∶2), creatinine, lysoPC (16∶0) and lysoPE(22∶0/0∶0) in the FLP-treated group were completely reversed to levels in the control group which lacked CKD. Combined with biochemistry and histopathology results, the changes in serum metabolites indicate that the perturbations of phospholipids metabolism, energy metabolism and amino acid metabolism are related to adenine-induced CKD and to the interventions of FLP on all the three metabolic pathways. FLP may regulate the metabolism of these biomarkers, especially their efficient utilization within the context of CKD. Furthermore, these biomarkers might serve as characteristics to explain the mechanisms of FLP.
机译:ia(Fu-Ling-Pi,FLP)的表层是中药常用的,其利尿作用已在大鼠中得到证实。采用超高效液相色谱/四极杆飞行时间高灵敏度质谱法和新型质谱法 Elevated Energy 数据收集技术,研究腺嘌呤过量引起的慢性肾脏疾病(CKD)的代谢组学特征。和FLP的保护作用。在CKD中检测到多种代谢物,它们与进行性肾损伤相关。在这些生物标志物中,FLP治疗组中的lysoPC(18∶0),四二十碳六烯酸,lysoPC(18∶2),肌酐,lysoPC(16∶0)和lysoPE(22∶0 / 0∶0)被完全逆转为缺乏CKD的对照组的血脂水平。结合生物化学和组织病理学结果,血清代谢产物的变化表明,磷脂代谢,能量代谢和氨基酸代谢的扰动与腺嘌呤诱导的CKD和FLP对这三种代谢途径的干预有关。 FLP可能调节这些生物标记物的代谢,特别是在CKD范围内有效利用它们。此外,这些生物标志物可以作为解释FLP机制的特征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号